Sachin Bansal, Binny Bansal and others invest $5.8 m in SigTuple

Moneycontrol BureauBangalore-based healthtech startup SigTuple has raised USD 5.8 million in Series A funding led by Accel Partners with participation from IDG Ventures, Endiya Partners, pi Ventures, VH Capital, Axilor Partners and other investors including Sachin Bansal, Binny Bansal and Amit Singhal.

The company provides a data driven, machine-learned, cloud-based solution to improve the accuracy and efficiency in disease diagnosis. To gain insights from data the company have a machine learning platform called Kurma.

Founded by three IITians Rohit, Apurv and Tathagato, SigTuple plans to revolutionise global healthcare space through data driven intelligence. The startup also raised USD 740,000 in October 2015 from Sachin Bansal, Binny Bansal, Accel Partners, Ashok Bareja, Dr. Nirupa Bareja and Debanjan Mukherjee.

“Our goal is to develop intelligent, scalable and affordable disease screening solutions which can empower medical experts and facilitate quality healthcare delivery to the masses. Our initial focus is on the solutions for the screening tests so that we can positively impact a larger population not only in India but globally”said, Rohit Kumar Pandey, Co-founder and CEO, SigTuple.

Barath Shankar Subramanian, Accel Partners, added, “When we evaluate opportunities, one of the most important things we look at is the fit between the founders and the business opportunity. In this case, the AI/ML part of the business is the core and the background of the founders was a great fit. We believe that they have a well thought through approach to the problem and hence we decided to back them”.

As of Feb 2017, the company is providing solutions for automated analysis of blood, urine and semen samples, retinal scans and chest x-rays through its continuous learning platform called Manthana which has capability to train, validate and execute AI and ML powered models to classify various objects of interest, detect diseases and compute the metrics for reporting.

“SigTuple is one of those home-grown companies which has potential to compete globally. I strongly believe that the products they are developing will revolutionise healthcare delivery not only in India but globally”, said Binny Bansal Group CEO, Flipkart.

Currently, SigTuple is working with large hospitals and labs and a group of medical experts for the solution for blood, Shonit™, which has already undergone 3 clinical trials. Follow @startup_18